key: cord-1052737-c8sxc7kj
authors: Mi, Xiaona; Li, Hui; Tan, Rong; Feng, Bainian; Tu, Yifeng
title: The TDs/aptamer cTnI Biosensors Based on HCR and Au/Ti3C2-MXene Amplification for Screening Serious Patient in COVID-19 Pandemic
date: 2021-07-06
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2021.113482
sha: 5debf5e40ffcb4153487a073d8babbcfc0e2b33f
doc_id: 1052737
cord_uid: c8sxc7kj

The accurate assay of cardiac troponin I (cTnI) is very important for acute myocardial infarction (AMI), it also can be employed as an effective index for screening serious patients in COVID-19 pandemic before fatal heart injury to reduce the mortality. A ratiometric sensing strategy was proposed based on electrochemiluminescent (ECL) signal of doxorubicin (Dox)-luminol or the electrochemical (EC) signal of methylene blue (MB) vs. referable EC signal of Dox. The bio-recognitive Tro4-aptamer ensures the high specificity of the sensor by affinity binding to catch cTnI, and the tetrahedral DNA (TDs) on Au/Ti3C2-MXene built an excellent sensing matrix. An in situ hybrid chain reaction (HCR) amplification greatly improved the sensitivity. The ratiometric sensing responses ECL Dox-luminol/Current Dox or Current MB/Current Dox linearly regressed to cTnI concentration in the range of 0.1 fM-1 pM or 0.1 fM-500 fM with the limit of detection (LOD) as 0.04 fM or 0.1 fM, respectively. Served as the reference signal, Current Dox reflected the variation of sensor, it is very effective to ensure the accuracy of detection to obviate the false results. The proposed biosensors show good specificity, sensitivity, reproducibility and stability, have been applied to determine cTnI in real samples with satisfactory results. They are worth looking forward to be used for screening serious patient of COVID-19 to reduce the mortality, especially in mobile cabin hospital.

The global pandemic of COVID-19 pneumonia has lasted for more than one year 2 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). According to 3 clinical researches, its high mortality directly relates to severe cases such as cardiac 4 complications (Lukas et al., 2020; Shirazi et al., 2020) . Cardiac troponin I (cTnI, high 5 sensitivity troponin) is acknowledged as the most prominent biomarker for heart failure 6 as in acute myocardial infarction (AMI), on account of its excellent specificity and 7 sensitivity, also can provide long enough diagnostic window for myocardial injury (Han 8 et al., 2016; Yang, R. et al., 2019), its level in the blood mirrors the degree of myocardial 9 injury, so the accuracy and sensitivity of cTnI measurements is of great significance for 10 suspected heart patients (Zhu et al., 2019b) . With a threshold of 0.04 ng/ml, a positive 11 result of the cTnI concentration as 0.1 ng/ml clearly relates to microcirculation in acute 12 myocardial infarction (Micro-AMI) patients (Fathil et al., 2015) and as high as 5 to 50 13 ng/ml for large AMI patients (Sun et al., 2019) . Early, sensitive and accurate detection 14 of AMI biomarkers can reduce mortality assuredly . The reports also 15 revealed the cTnI rise in those COVID-19 patients (Guo et al., 2020; Huang et al., 2020) , 16 indicating that this index is important to identify severe cases from those mild patients, 17 thus to take timely medical measures and therefore to reduce the mortality. 18 Until now, lots of researches focused on cTnI detection using immunosensors 19 (Dong et al. (ssDNA) or RNA produced in vitro with higher selectivity and affinity for proteid 7 biomarker than antibody (Dhara and Mahapatra, 2020; Tao et al., 2020). 8 Herein the density and orientation of bio-recognitive probe on sensor surface is a 9 core factor needed to be managed. Tetrahedral DNA (TDs) nanostructures, a novel 10 "bottom-up" scaffolding strategy for probe loading, can perfectly regulate the density 11 and orientation of probe packing. Also it provides the solution-phase-like environment 12 to improve the probe-target recognition efficiency by effective elimination of In this work, an elegant sensing strategy was achieved for sensitive and accurate 

Another sensor with EC signal of methylene blue (MB, an electroactive indicator), 6 enhanced in the presence of cTnI, also presented the sensing ability for cTnI (Current 9 2. 1. Reagents, apparatus and materials preparation 10 These contents are described in Supplementary Material (S1-S6). 11 12 Prior to use, indium tin oxide (ITO) glasses were cleaned according to the previous suspension (l.5 mg/mL) was cast on this surface and kept at room temperature for 2 h, 16 followed by rinsing with water and drying with N2. Then, 10 µL of TDs solution (1 µM) 17 was incubated on at 4 °C for 12 h (TDs/Au/Ti3C2-MXene/ITO). TDs is anchored onto 18 the surface of Au/Ti3C2-MXene/ITO via Au-S bonds from thiol groups at three vertices, 19 emerged a pendant single DNA strand on last vertex. After that, 10 µL of Dox (2.0 mM) 20 was placed on the sensing surface and incubate for 4 h at the room temperature to make 21 them embedded into all edges of TDs. 22 After to incubate cTnI with BFP/Tro4-aptamer/Au@Fe3O4, equal amount of BFP 23 was released. Driven out those magnetic components by external magnet, as-prepared 24 TDs/Au/Ti3C2-MXene/ITO was immersed in it for 1.5 h at 37 °C. After washing, 10 μL 11 3. 1. Principle of the ratiometric aptasensing strategy 12 Scheme 1 illustrates the principle and construction of the ratiometric aptasensors. 13 These TDs-supported probes greatly improve the target accessibility and minimize the 14 non-specific adsorption on the sensor surface owing to its spatial structure, functional 15 groups and dsDNA edge. A new bifunctional probe (BFP) (sequences in Table S1 ) was 16 ingeniously designed and employed to rise specific hybridization and also to trigger 17 HCR. In blank case, beside distinct SWV signal of Dox at -0.65 V, only very weak ECL 18 signal of Dox-luminol or SWV signal of MB around -0.24 V were detected. Oppositely, 19 the specific affinity reaction of cTnI with Tro4-aptamer liberated equal amount of BFP 20 (as shown in Scheme 1a), initiated its hybridization with the capture DNA at vertex of 21 TDs, meanwhile another part of BFP triggered the HCR with the coexistence of two biosensing mechanism for cTnI. 13 14 15 1 To confirm the successful assembly of TDs (the details of the preparation is 2 presented in SM, S2, and the Table S1 listed those sequences) and HCR, agarose gel shows that the AuNPs with < 30 nm of diameter were decorated on the Ti3C2-MXene 12 nanosheets (inserted in Fig. 2A ). The XRD curve in Fig. 2B indicates the disappearance 13 of the characteristic peak of Ti3AlC2 (curve a) at 39° and the shift of (002) peak to lower The elemental valences of Ti in Ti3C2-MXene, The elemental valence of (G) Ti and (H) Au in Au/ 5

Ti3C2-MXene. 6 1 curves of different electrodes are recorded (in Fig. 3A) . A couple of reversible redox 2 peaks around 0.2 V was observed on bare ITO (curve a). When APTMS was grafted on 3 it, peak currents decreased due to its poor conductivity (curve b). After Au/Ti3C2- 4 MXene nanosheets were attached on by Au-N bond, larger peak currents appeared, 5 because of the excellent conductivity of AuNPs and Ti3C2-MXene nanosheets (curve c). 6 According to Randles-Sevcik equation, the electrochemical active area of Au/Ti3C2- 7 MXene/ITO can be calculated to be 0.65 cm 2 (see detailed discussion in S8, SM). Then, 8 TDs probes were assembled on, inducing distinctly decrease in peak current because of and presence of cTnI. 8 9 To further validate the feasibility of the ECL/EC ratiometric strategy, the 10 alteration of ECL intensities and SWV signals were recorded in conditions of whether 11 is there a target. As displayed in Fig. 3C , in the absence of cTnI, occupied by hairpins, 12 little amount of Dox-luminol can interact onto sensor surface, giving only weak ECL 13 signal. Thereafter, along with the increase of cTnI concentration, the ECL signal was significantly enhanced. A significant SWV signal of Dox intercalated in TDs at -0.65 V 1 shows small distinction upon different sensor or microenvironment, implying that the 2 EC signal of Dox was uncorrelated to the target. Hence, the ratio of ECL Dox-3 Luminol/Current Dox could eliminate the variation of sensor to improve the accuracy of 4 detection. The ECL emission of luminol raised at about 1.3 V (Fig. 3C, inset) , without 5 cross action with the oxidation potential of Dox. So the stable EC signal of Dox can be 6 employed as the reference signal. Likewise, the feasibility of the EC/EC ratiometric 7 strategy was also confirmed in Fig. 3D , similarly, cTnI concentration can be calibrated 3. 5. cTnI aptasensing 10 The analytical performances of the proposed ratiometric biosensors for cTnI were 11 investigated under the optimal conditions (see S10 in SM): 0.20 % APTMS, 1.5 mg/ml aptasensor, but nothing changed anymore in sensing process (column "g", shown in Fig.   3 S10), demonstrates the exclusive necessity of Tro4-aptamer for sensor response, 4 verdicting that the binding of the Tro4-aptamer with the target triggered the HCR 5 amplification process (see detailed discussion in S11, SM). In summary, compared to 6 reported bioassays of cTnI (Table S2) , these two sensors displayed higher sensitivity. 7 The specificity of the sensors was evaluated toward cTnI against four potential Fig. 4E ) was 3.27 %, and RSD of EC signal was 2.33 %, respectively, 17 suggesting that the designed biosensors were stable. the AMI patient were examined parallelly with sensors and ELISA kit (Table 1) , got a 4 small error less than 6.0 %, indicating good accuracy of the proposed biosensors. 

In this research, fascinating ratiometric ECL/EC and EC/EC aptasensors were 11 constructed by integrating aptamer-based molecular recognition with the ECL or EC 12 signal transduction and dual amplification for cTnI detection. As we all know, people 13 with one or more high risk factors such as hypertension, hyperlipidemia, thrombus etc, 14 need early and regular medical inspection to manage their daily life although who has 15 not yet shown any AMI symptoms like pectoralgia; for people who have had 16 myocardial infarction, it is indispensable to monitor the condition more frequently. 1 AMI biomarkers as cTnI in peripheral blood is a more preferable way. Take the lead to 2 design cTnI sensor with two-channel signal outputs in this work, more accurate 3 detection is expectable with lower-level of false result, because the false results in AMI 4 diagnosis is a life-threatening factor. It will help the improvement of reliability of 5 clinical assay, thereafter to promote the comprehensive benefits of medical therapy. 6 Meanwhile, beside ELISA, with higher sensitivity attributed to the ability of multi- 

Anal